Genes, proteases, cortical spreading depression and migraine: Impact on pathophysiology and treatment

Functional Neurology

Volumn 22, Issue 3, 2007, Pages 133-136

  Moskowitz, Michael A ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Ion channel; Migraine; Neurogenic inflammation; Pathophysiology; Spreading depression; Trigeminal nerve

Indexed keywords

AMITRIPTYLINE; ANTIMIGRAINE AGENT; CALCIUM; DIHYDROERGOTAMINE; METHYSERGIDE; NEUROPEPTIDE; OLCEGEPANT; POTASSIUM; PROPRANOLOL; PROTEINASE; SODIUM; SUMATRIPTAN; TOPIRAMATE; TRIPTAN DERIVATIVE; VALPROIC ACID;

AUTONOMIC NERVOUS SYSTEM FUNCTION; CALCIUM TRANSPORT; CARDIOVASCULAR SYSTEM; DISEASE PREDISPOSITION; GENETIC SUSCEPTIBILITY; HEADACHE; HUMAN; MIGRAINE; MIGRAINE AURA; NONHUMAN; PATHOPHYSIOLOGY; POINT MUTATION; POTASSIUM TRANSPORT; REVIEW; SODIUM TRANSPORT; SPREADING CORTICAL DEPRESSION; TRIGEMINAL NERVE;

ANIMALS; CEREBROVASCULAR CIRCULATION; HUMANS; MIGRAINE DISORDERS; PEPTIDE HYDROLASES; SPREADING CORTICAL DEPRESSION; TRIGEMINAL NERVE;

EID: 35348939022     PISSN: 03935264     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (47)

1. Moskowitz MA, Reinhard JF, Romero J, Melamed E, Pettibone DJ. Neurotransmitters and the fifth cranial nerve. Is there a relation to the headache phase of migraine. Lancet 1979;2:883-885
2. Moskowitz MA. Pathophysiology of headache - past and present. Headache 2007;47(Suppl 1):S58-S63
3. Moskowitz MA. The visceral organ brain: implications for the pathophysiology of vascular head pain. Neurology 1991;41:182-186
4. Malick A, Burstein R. Cells of origin of the trigeminohypothalamic tract in the rat. J Comp Neurol 1998;400:125-144
5. Moskowitz MA. The neurobiology of vascular head pain. Ann Neurol 1984;16:157-168
6. Markowitz S, Saito K, Moskowitz MA. Neurogenically mediated leakage of plasma protein occurs from blood vessels in dura mater but not brain. J Neurosci 1987;7:4129-4136
7. Goadsby PJ, Edvinsson L, Ekman R. Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Ann Neurol 1990;28:183-187
8. Arnold G, Reuter U, Kinze S, Wolf T, Einhaupl KM. Migraine with aura shows gadolinium enhancement which is reversed following prophylactic treatment. Cephalalgia 1998;18:644-646
9. Lindner A, Reiners K, Toyka KV. Meningeal hyperperfusion visualized by MRI in a patient with visual hallucinations and migraine. Headache 1996;36:53-57
10. Smith M, Cros D, Sheen V. Hyperperfusion with vasogenic leakage by fMRI in migraine with prolonged aura. Neurology 2002;58:1308-1310
11. Barbour PJ, Castaldo JE, Shoemaker EI. Hemiplegic migraine during pregnancy: unusual magnetic resonance appearance with SPECT scan correlation. Headache 2001; 41:310-316
12. Iizuka T, Sakai F, Suzuki K, Igarashi H, Suzuki N. Implication of augmented vasogenic leakage in the mechanism of persistent aura in sporadic hemiplegic migraine. Cephalalgia 2006;26:332-335
13. Crawford JS, Konkol RJ. Familial hemiplegic migraine with crossed cerebellar diaschisis and unilateral meningeal enhancement. Headache 1997;37:590-593
14. Dreier JP, Jurkat-Rott K, Petzold GC et al. Opening of the blood-brain barrier preceding cortical edema in a severe attack of FHM type II. Neurology 2005;64:2145-2147
15. Burstein R. Deconstructing migraine headache into peripheral and central sensitization. Pain 2001;89:107-110
16. Burstein R, Cutrer MF, Yarnitsky D. The development of cutaneous allodynia during a migraine attack clinical evidence for the sequential recruitment of spinal and supraspinal nociceptive neurons in migraine. Brain 2000; 123:1703-1709
17. Buzzi MG, Carter WB, Shimizu T, Heath H, Moskowitz MA. Dihydroergotamine and sumatriptan attenuate levels of CGRP in plasma in rat superior sagittal sinus during electrical stimulation of the trigeminal ganglion. Neuropharmacology 1991;30:1193-1200
18. Levy D, Jakubowski M, Burstein R. Disruption of communication between peripheral and central trigeminovascular neurons mediates the antimigraine action of 5HT 1B/1D receptor agonists. Proc Natl Acad Sci U S A 2004;101: 4274-4279
19. Goadsby PJ, Edvinsson L. The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats. Ann Neurol 1993;33:48-56
20. Olesen J, Diener HC, Husstedt IW et al. Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine. N Engl J Med 2004;350:1104-1110
21. Milner PM. Note on a possible correspondence between the scotomas of migraine and spreading depression of Leão. Electroencephalogr Clin Neurophysiol Suppl 1958; 10:705
22. Lauritzen M. Pathophysiology of the migraine aura. The spreading depression theory. Brain 1994;117:199-210
23. Moskowitz MA, Nozaki K, Kraig RP. Neocortical spreading depression provokes the expression of c-fos protein-like immunoreactivity within trigeminal nucleus caudalis via trigeminovascular mechanisms. J Neurosci 1993;13:1167-1177
24. Bolay H, Reuter U, Dunn AK, Huang, Z, Boas DA, Moskowitz MA. Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model. Nat Med 2002;8: 136-142
25. Iadecola C. From CSD to headache: a long and winding road. Nat Med 2002;8:110-112
26. Bowyer SM, Aurora KS, Moran JE, Tepley N, Welch KM. Magnetoencephalographic fields from patients with spontaneous and induced migraine aura. Ann Neurol 2001;50: 582-587
27. Somjen GG. Mechanisms of spreading depression and hypoxic spreading depression-like depolarization. Physiol Rev 2001;81:1065-1096
28. Hadjikhani N, Sanchez Del Rio M, Wu O et al. Mechanisms of migraine aura revealed by functional MRI in human visual cortex. Proc Natl Acad Sci U S A 2001;98: 4687-4692
29. Leão AA. Spreading depression of activity in cerebral cortex. J Neurophysiol 1944;7:359-390
30. Leão AA. Pial circulation and spreading depression of activity in the cerebral cortex. J Neurophysiol 1944;7:391-396
31. Sanchez del Rio M, Alvarez Linera J. Functional neuroimaging of headaches. Lancet Neurol 2004;3:645-651
32. Woods RP, Iacoboni M, Mazziotta JG. Brief report: bilateral spreading cerebral hypoperfusion during spontaneous migraine headache. N Engl J Med 1994;331:1689-1692
33. Cao Y, Aurora SK, Nagesh V, Patel SC, Welch KM. Functional MRI-BOLD of brainstem structures during visually triggered migraine. Neurology 2002;59:72-78
34. Ayata C, Jin H, Kudo C, Dalkara T, Moskowitz MA. Suppression of cortical spreading depression in migraine prophylaxis. Ann Neurol 2006;59:652-661
35. Gursoy-Ozdemir Y, Qiu J, Matsuoka N et al. Cortical spreading depression activates and upregulates MMP-9. J Clin Invest 2004;113:1447-1455
36. van der Kamp W, MaassenVanDenBrink A, Ferrari MD, van Dijk JG. Interictal cortical excitability to magnetic stimulation in familial hemiplegic migraine. Neurology 1997; 48:1462-1464
37. Welch KM. Brain hyperexcitability: the basis for antiepileptic drugs in migraine prevention. Headache 2005;45(Supp1 1):S25-32
38. Bohotin V, Fumal A, Vandenheede M et al. Effects of repetitive transcranial magnetic stimulation on visual evoked potentials in migraine. Brain 2002;125:912-922
39. Schoenen J, Ambrosini A, Sandor PS, Maertens de Noordhout, A. Evoked potentials and transcranial magnetic stimulation in migraine: published data and viewpoint on their pathophysiologic significance. Clin Neurophysiol 2003;114: 955-972
40. van den Maagdenberg AM, Pietrobon D, Pizzorusso T et al. A Cacna1a knockin migraine mouse model with increased susceptibility to cortical spreading depression. Neuron 2004;41:701-710
41. Ophoff RA, Terwindt GM, Vergouwe MN et al. Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Cell 1996;87:543-552
42. De Fusco M, Marconi R, Silvestri L, et al. Haploinsufficiency of ATP1A2 encoding the Na+/K+ pump alpha2 subunit associated with familial hemiplegic migraine type 2. Nat Genet 2003;33:192-196
43. Dichgans M, Freilinger T, Eckstein G et al. Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine. Lancet 2005;366:371-377
44. Moskowitz MA, Bolay H, Dalkara T. Deciphering migraine mechanisms: clues from familial hemiplegic migraine genotypes. Ann Neurol 2004;55:276-280
45. Meeks JP, Mennerick S. Selective effects of potassium elevations on glutamate signaling and action potential conduction in hippocampus. J Neurosci 2004;24:197-206
46. Jen JC, Wan J, Palos TP, Howard BD, Baloh RW. Mutation in the glutamate transporter EAAT1 causes episodic ataxia, hemiplegia, and seizures. Neurology 2005;65:529-534
47. Magistretti PJ, Pellerin L, Rothman DL, Shulman RG. Energy on demand. Science 1999;283:496-497